Plus Therapeutics Inc PSTV:NASDAQ

RT Quote | USD
Last | 04/24/24 EDT
1.60quote price arrow down-0.03 (-1.84%)
Volume
8,438
52 week range
0.97 - 5.09
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.63
  • 52 Week High5.09
  • 52 Week High Date05/11/23
  • 52 Week Low0.97
  • 52 Week Low Date10/25/23

Key Stats

  • Market Cap6.842M
  • Shares Out4.28M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.57
  • YTD % Change-8.58

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.63
  • 52 Week High5.09
  • 52 Week High Date05/11/23
  • 52 Week Low0.97
  • 52 Week Low Date10/25/23
  • Market Cap6.842M
  • Shares Out4.28M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.57
  • YTD % Change-8.58

RATIOS/PROFITABILITY

  • EPS (TTM)-4.51
  • P/E (TTM)-0.36
  • Fwd P/E (NTM)-0.53
  • EBITDA (TTM)-12.693M
  • ROE (TTM)-522.50%
  • Revenue (TTM)4.913M
  • Gross Margin (TTM)20.13%
  • Net Margin (TTM)-271.04%
  • Debt To Equity (MRQ)-294.96%

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Plus Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers. The Company combines image-guided local beta radiation and targeted drug delivery approaches. The Company is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). Its radiotherapeutic candidate, rhenium...
Richard Hawkins
Independent Chairman of the Board
Marc Hedrick M.D.
President, Chief Executive Officer, Director
Andrew Sims CPA
Chief Financial Officer
Pius Maliakal Ph.D.
Vice President - Clinical Operations
Address
4200 Marathon Blvd Ste 200
Austin, TX
78756-3433
United States

Top Peers

SYMBOLLASTCHG%CHG
KA
Kineta Inc
0.62-0.0498-7.4351%
PULM
Pulmatrix Inc
2.02UNCHUNCH
ATHXQ
Athersys Inc
0.0045UNCHUNCH
BLPH
Bellerophon Therapeutics Inc
0.0541UNCHUNCH
OPGN
OpGen Inc
0.563-0.05-8.1566%